Cover Image

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?

Natalie Klag, Adam C Walter, Kristen M Sheely, Kelly J Manahan, John P Geisler Division of Gynecologic Oncology, Cancer Treatment Centers of America Newnan, Georgia, USA Background: New chemotherapy combinations are being tested for the treatment of women with advanced, persistent or recurrent cervi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Klag N (Author), Walter AC (Author), Sheely KM (Author), Manahan KJ (Author), Geisler JP (Author)
Format:	Book
Published:	Dove Medical Press, 2016-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy
by: Valerie A. Allen, et al.
Published: (2016)

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer
by: Michiko Nonaka, et al.
Published: (2018)

Management of recurrent cancer of the uterine cervix
by: Aditi Bhatt, et al.
Published: (2011)

Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
by: Abigail S. Zamorano, et al.
Published: (2017)

Prognostic impact of adding bevacizumab to carboplatin and paclitaxel for recurrent, persistent, or metastatic cervical cancer
by: Masafumi Yasunaga, et al.
Published: (2022)

Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer
by: Ioannis Alagkiozidis, et al.
Published: (2015)

Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
by: Rose Isono-Nakata, et al.
Published: (2018)

Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ovarian cancer patients
by: Soshi Kusunoki, et al.
Published: (2018)

Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis
by: Wanjun Tao, et al.
Published: (2020)

Role of magnetic resonance imaging in the diagnosis of recurrent cancer of the cervix uteri
by: Z. N. Shavladze, et al.
Published: (2014)

Metronomic chemotherapy using oral cyclophosphamide and bevacizumab for recurrent cervical cancer: A multi-institutional retrospective study
by: Roze Isono-Taniguchi, et al.
Published: (2022)

Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
by: Madison R. Klavans, et al.
Published: (2020)

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer
by: Xia Luo, et al.
Published: (2022)

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
by: Shoji Nagao, et al.
Published: (2020)

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022
by: Laura Torres-Canchala, et al.
Published: (2022)

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
by: Fenge Jiang, et al.
Published: (2022)

Bevacizumab for glioblastoma
by: Narita Y
Published: (2015)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
by: Yoshida H, et al.
Published: (2015)

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain
by: Lister J, et al.
Published: (2012)

Potential benefit of using phenazopyridine to detect multiple vesicovaginal fistulas for primary repairs on medical mission trips in Cote d'Ivoire
by: Matthew A. Geisler, et al.
Published: (2022)

Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series
by: Shannon M. Glynn, et al.
Published: (2024)

The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in the treatment of recurrent glioblastoma: a case report
by: Wangyan Zhong, et al.
Published: (2024)

Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
by: Hongfu Cai, et al.
Published: (2024)

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
by: Frontiers Production Office
Published: (2022)

Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review
by: Yuki Karasawa, et al.
Published: (2022)

Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix
by: Lia Bos, et al.
Published: (2021)

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
by: Tae Hyun Kim, et al.
Published: (2023)

Clinical case use bevacizumab for patient with metastatic ovarian cancer
by: M. R. Oganyan, et al.
Published: (2014)

Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer
by: Thérèse H Franco, et al.
Published: (2008)

Multiple isolated ovarian cancer recurrences in the cervix and vagina after supracervical hysterectomy: A case report
by: Anh Q. Nguyen, et al.
Published: (2022)

Cancer of the Uterine Cervix
by: Franco Eduardo L, et al.
Published: (2004)

Cáncer de cervix
by: Néstor H. Amorocho, et al.
Published: (1986)

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
by: Di Cao, et al.
Published: (2023)

Bevacizumab-Induced Geographic Tongue
by: Marta Martinez-Garcia, et al.
Published: (2021)

Monitoring antiangiogenesis of bevacizumab in zebrafish
by: Zhang J, et al.
Published: (2018)

The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review
by: Mohammed Osman
Published: (2014)

Chemotherapy for advanced or recurrent cervical cancer
by: Toshiharu Kamura, et al.
Published: (2013)

Sexuality of women with cervix cancer after treatment: literature review
by: Nur Afni Sharfina, et al.
Published: (2021)

Symbiosis of chemotherapy and aggressive cancer surgery in improving the results of treatment for locally advanced cancer of the cervix uteri
by: G. A. Khakimov, et al.
Published: (2016)